[1]
Y. T. Wang, W. T. Wu, W. J. Wu. "An overview and features of development of Chinese biopharmaceutical enterprises," Pharmaceutical Biotechnology, Vol. 17 (2010), pp.1-14
Google Scholar
[2]
S. M. Wen. "The Global Development of the biopharmaceutical industry.,"China Biotechnology, Vol. 26 (2006), pp.92-96
Google Scholar
[3]
Ministry of Environmental Protection of P.R. China. "The policies of preventional technologies for pharmaceutical industry," 2009, pp.17-19
Google Scholar
[4]
Ministry of Environmental Protection of P.R. China. "National discharge criteria of water pollutants of bio-pharmaceutical industry (GB21907 – 2008)," (2008)
Google Scholar
[5]
H. R. Sun, X. L. Wang. "The research progress of environmental risk forcasting technologies for pharmaceutical industrial water pollutants," Environmental Science & Technology , 2011 (in press)
Google Scholar
[6]
X. M. Zheng, Z. Feng, L. Ding, H. L. Liu, H. X. Yu. "Review of online biological monitoring systems with the use of daphnia Magna," Environmental Monitoring and Forewarning, Vol.3 (2011), pp.21-24
Google Scholar
[7]
R. X. Hao, H. W. Wan, Y.Zhang, Y. T. Zhang, Y.W. Zhou. "Environmental risk assessment on nonylphenol supplying reclaimed wastewater for urban lake," Journal of beijing university of technology , Vol. 34 (2008), pp.626-630
Google Scholar
[8]
H. R. Sun, Y. Xue, X. L. Ma, X. L. Wang. "An assessment model for the risk of wastewater of pharmaceutical manufacturers (mixing and formulation) taking methane-oxidizing bacteria as an indicator," The 2011 International Conference on Green Energy And Environmental Sustainable Development , (2011), in press
Google Scholar
[9]
H.R. Sun, Q. Zou, X. L. Wang. "An environmental risk assessment model for the chemical synthestic pharmaceutical wastewater by euglena," The 2nd Academic Conference on Energy: Environment and Development, (2011), in press
Google Scholar
[10]
J. H. Han, Y. L. Wang, L. S. Si. "Study on fermentation for recombinant bacterial strain of human interleukin-6," Journal of xi'an medical university, Vol. 22 (2001), pp.502-504
Google Scholar
[11]
P. H. Wei, T. Wu, W. T. Wu, J. Yu. "Construction of low-specificity L-threonine aldolase genetic engineered strain," Pharmaceutical Biotechnology, Vol. 7 (2000), pp.86-89
Google Scholar
[12]
K. A. Haynes, M. L. Broderick, A. D. Brown, T. L. Butner, J. O. Dickson, W. L. Harden, et al. "Engineering bacteria to solve the burnt pancake problem," Journal of Biological Engineering,Vol. 2 (2008), pp.8-20
DOI: 10.1186/1754-1611-2-8
Google Scholar